1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Cannabis-Tied Mystery Pharmaceutical Interest Eyeing Large Property Concerns Many

  1. Beenthere2Hippie
    Pharmaceutical interests with ties to cannabis are reported to be involved in talks to purchase Longmont’s largest commercial property: The 70-acre facility formerly home to biotech firm Amgen.

    The campus was put up for sale in June for an asking price of $85 million, following the listing of Amgen’s 300,000-square-foot Boulder facility. That property was purchased for $14.6 million by AstraZeneca in September.

    Greenwood Village-based Binswanger was tapped to list both properties. The real estate organization did not broker the AstraZeneca deal, senior vice president Eric Dienstbach told the Denver Post in September, but is currently marketing the Longmont property. Dienstbach confirmed this week that at least two interested parties are involved in negotiations for the property — including one with ties to cannabis.

    One interested party is “a consortium of doctors, scientists and pharmaceutical products — let’s call them natural products — that have an idea for the property that might include some by products of marijuana,” Dienstbach said. “It’s a big plan; it has a lot of moving parts to it.”

    The other party is a “more typical corporate entity,” he said.

    Marijuana businesses are banned within Longmont city limits, per a 4-2 vote of the city council in 2013. But production of non-psychoactive cannabidiol (CBD), a chemical compound derived from hemp plants, is not. CBD, touted for its pain-relieving and anti-inflammatory properties, is most frequently used in medical applications.

    Boulder-based CBDRx last year harvested 50,000 pounds of hemp for use in “cannaceuticals.” The company has a research and development facility in Longmont, but officials said they didn’t know who the potential buyer might be. Very few companies in the cannabis space have the capital needed to purchase the sprawling facility — unless banded together in a “consortium” — and only a handful of bigger players are working with CBD.

    The unnamed potential buyer is using a local agent, Dienstbach said, and a deal is likely two to three months away.

    “We still have quite a bit of discussion to go.”



    By Shay Castle - The Cannabis/Feb. 13, 2016
    http://www.thecannabist.co/2016/02/...-eyeing-longmonts-biggest-biz-property/48130/
    Newshawk Crew

    Author Bio

    Beenthere2Hippie
    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.

Comments

To make a comment simply sign up and become a member!